Advertisement

The Scientist

» cancer and immunology

Most Recent

image: Designing Transition-State Inhibitors

Designing Transition-State Inhibitors

By | May 1, 2012

A transition-state mimic has the power to bind an enzyme at its tipping point as strongly as any available inhibitor and more strongly than most, preventing enzymatic activity. 

0 Comments

image: Pure Pursuits

Pure Pursuits

By | May 1, 2012

Techniques for simpler, cheaper, and better antibody purification

0 Comments

image: Tumor Turnabout

Tumor Turnabout

By | May 1, 2012

A cytokine involved in suppressing the immune system may actually activate it to kill cancer cells.

4 Comments

image: Freezing Time

Freezing Time

By | May 1, 2012

Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.

15 Comments

image: Telomeres in Disease

Telomeres in Disease

By | May 1, 2012

Telomeres have been linked to numerous diseases over the years, but how exactly short telomeres cause diseases and how medicine can prevent telomere erosion are still up for debate.

16 Comments

image: Anti-inflammatory Factors Fight Bugs

Anti-inflammatory Factors Fight Bugs

By | April 25, 2012

A combination of antibiotics and the body’s own defensive metabolites clears bacterial infections faster than antibiotics alone.

4 Comments

image: The Best of Experimental Biology

The Best of Experimental Biology

By | April 25, 2012

From breast milk stem cells to bone repair, this year’s EB conference held a number of exciting advances that could one day be translated into therapies.

4 Comments

image: Huntington's Disease Protects from Cancer?

Huntington's Disease Protects from Cancer?

By | April 13, 2012

Swedish researchers have discovered that patients with the neurodegenerative disorder had half the normal expected risk of developing tumors.

6 Comments

image: Social Rank Affects Monkey Immunity

Social Rank Affects Monkey Immunity

By | April 11, 2012

In rhesus macaques, an individual's drop in the social hierarchy leads to overactive immune genes and, possibly, poor health.

0 Comments

image: A Universal Cancer Vaccine?

A Universal Cancer Vaccine?

By | April 10, 2012

A vaccine that targets 90 percent of all cancers shows promise in early clinical trials.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Brady
Brady
Advertisement